A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin
Part of paid clinical trials in Little Rock, Arkansas.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT05275400
- Phase
- PHASE3
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Insulin Efsitora Alfa — DRUGAdministered SC
- Insulin Degludec — DRUGAdministered SC
Study Details
The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.
Key Dates
- Start date
- Mar 8, 2022
- Status verified
- May 2025
- Primary completion
- May 15, 2024
- Completion
- May 15, 2024
Study Design
- Enrollment
- 986 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 500 U/mL - Insulin EfsitoraParticipants received 500 units per milliliter (U/mL) Insulin Efsitora Alfa (insulin efsitora) administered subcutaneously (SC) once weekly (QW).
- Active Comparator: 100 U/mL - Insulin DegludecParticipants received 100 U/mL insulin degludec administered SC once daily (QD).
Primary Outcome Measure
Change From Baseline in Hemoglobin A1c (HbA1c) [Noninferiority] [ Time Frame: Baseline, Week 26 ]
Locations (38)
Related coverage on Hipa.ai
- Liraglutide Alias Insulin Degludec Requires Higher Weekly Dose Than Efsitora…Liraglutide · Jun 3, 2025 · ClinicalTrials.gov
Find similar trials in Little Rock, AR
By condition
By specialty
By research site
Related Studies
- Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes PatientsPHASE1/PHASE2 · Not Yet Recruiting · ARKAY Therapeutics · Albany, New York
- The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older AdultsRecruiting · AdventHealth Translational Research Institute · Orlando, Florida
- Sleep and Glycemic Control in Type 2 Diabetes AdolescentsRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania
- Mechanisms of Fatigability With DiabetesRecruiting · University of Michigan · Ann Arbor, Michigan